Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-05-17 @ 1:18 PM
Study NCT ID:
NCT00611468
Status:
COMPLETED
Last Update Posted:
2011-08-22
First Post:
2008-01-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Solid Tumor | View |
Keywords: